AcousticaBio
PrivateLast Round
Early Funding
Apr 1, 2026
Total Funding Raised
$846,208
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AcousticaBio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in August 2024.
AcousticaBio is a biotechnology company that develops proprietary acoustophoretic technology to enable the formulation and subcutaneous delivery of biologic therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcousticaBio Comparables
Compare AcousticaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindy Biosciences | 87% | |
| Halozyme Therapeutics | 74% | |
| Huons Global Co Ltd | 73% |
For institutional investors. Book with your work email.
AcousticaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 1, 2026 | ||||
| Grant | Aug 1, 2024 | ||||
| Grant | Aug 1, 2023 | ||||
| Pre Seed | Jan 13, 2022 | ||||
| Grant | Oct 28, 2021 | ||||
Seed | Apr 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AcousticaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Massachusetts Life Sciences Center | Seed |
| Safar Partners | Seed, Pre Seed |
| MassChallenge Israel | Grant |
| 3CC | Third Culture Capital | Seed, Pre Seed |
| Exor | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 65% MoM, reaching 1.5K.
- Apr 1, 2026
Completed an early funding round.
For institutional investors. Book with your work email.
AcousticaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AcousticaBio's valuation, stock price, and market status.
Is AcousticaBio a public or private company?
AcousticaBio is a private company.
What is the current stock price of AcousticaBio?
AcousticaBio is a private company, so its shares have no public market price. Caplight tracks AcousticaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AcousticaBio worth (valuation)?
Valuation information for AcousticaBio is not publicly available.
Can I buy AcousticaBio stock?
AcousticaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AcousticaBio's last funding round?
AcousticaBio's most recent funding round was Early Funding on April 1, 2026.
Who are the main investors in AcousticaBio?
Key investors in AcousticaBio include Massachusetts Life Sciences Center.
Will AcousticaBio IPO soon?
No public IPO plans have been announced for AcousticaBio.
How can I track AcousticaBio secondary market activity?
Caplight tracks bids, offers, and trades in AcousticaBio's shares on secondary markets.